Prospective Nutraceutical Effects of Cinnamon Derivatives Against Insulin Resistance in Type II Diabetes Mellitus-Evidence From the Literature.
| Title: | Prospective Nutraceutical Effects of Cinnamon Derivatives Against Insulin Resistance in Type II Diabetes Mellitus-Evidence From the Literature. |
|---|---|
| Authors: | Mohsin SN; NIH, HRI, Research Center NHRC, Shaikh Zayed Post Graduate Medical Institute, Lahore, Pakistan.; Saleem F; Department of Biotechnology, Lahore College for Women University, Lahore, Pakistan.; Humayun A; Department of Public Health and Community Medicine, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan.; Tanweer A; Department of Nutrition & Dietetics, School of Health Sciences, University of Management and Technology, Lahore, Pakistan.; Muddassir A; Department of Medicine, Shaikh Zayed Post Graduate Medical Institute, Lahore, Pakistan. |
| Source: | Dose-response : a publication of International Hormesis Society [Dose Response] 2023 Sep 10; Vol. 21 (3), pp. 15593258231200527. Date of Electronic Publication: 2023 Sep 10 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 101308899 Publication Model: eCollection Cited Medium: Print ISSN: 1559-3258 (Print) Linking ISSN: 15593258 NLM ISO Abbreviation: Dose Response Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Publication: 2015- : Thousand Oaks, CA : Sage Publications; Original Publication: Amherst, MA : International Hormesis Society, c2005- |
| Abstract: | Apart from advances in pharmaceutical antidiabetic agents, efforts are being made toward hypoglycemic agents derived from natural sources. Cinnamon has been reported to have significant benefits for human health, particularly as an anti-inflammatory, antidiabetic, and anti-hypertriglyceridemic agent. The phytochemicals in cinnamon can be extracted from different parts of plant by distillation and solvent extraction. These chemicals help in decreasing insulin resistance and can act against hyperglycemia and dyslipidemia, inflammation and oxidative stress, obesity, overweight, and abnormal glycation of proteins. Cinnamon has shown to improve all of these conditions in in vitro, animal, and/or human studies. However, the mechanism of action of active ingredients found in cinnamon remains unclear. The current review presents the outstanding ability of cinnamon derivatives to control diabetes by various pathways modulating insulin release and insulin receptor signaling. It was also found that the type and dosage of cinnamon as well as subject characteristics including drug interactions are likely to affect the response to cinnamon. Future research directions based on this review include the synergistic usage of various cinnamon derivatives in managing and/or preventing diabetes and possible other relevant chronic diseases.; (© The Author(s) 2023.) |
| Competing Interests: | The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
| References: | J Family Community Med. 2012 May;19(2):68-73. (PMID: 22870408); Physiol Rev. 2018 Oct 1;98(4):2133-2223. (PMID: 30067154); Plant Foods Hum Nutr. 2019 Dec;74(4):544-552. (PMID: 31372918); Food Chem. 2012 Jun 1;132(3):1442-1450. (PMID: 29243634); Nat Rev Dis Primers. 2015 Jul 23;1:15019. (PMID: 27189025); J Agric Food Chem. 2007 Jul 11;55(14):5484-90. (PMID: 17567030); Iran Red Crescent Med J. 2014 Feb;16(2):e13426. (PMID: 24719730); Arch Biochem Biophys. 2007 Mar 15;459(2):214-22. (PMID: 17316549); Diabetes Care. 2004 May;27(5):1047-53. (PMID: 15111519); Nat Prod Res. 2021 Dec;35(24):5813-5827. (PMID: 33025819); J Intercult Ethnopharmacol. 2016 Feb 21;5(2):108-13. (PMID: 27104030); Fitoterapia. 2020 Oct;146:104675. (PMID: 32561421); Diabet Med. 2010 Oct;27(10):1159-67. (PMID: 20854384); Endocr Rev. 1999 Oct;20(5):649-88. (PMID: 10529898); PeerJ. 2019 Jun 20;7:e7022. (PMID: 31259094); BMJ Open. 2019 Feb 21;9(2):e025300. (PMID: 30796126); Biosci Biotechnol Biochem. 2010;74(12):2418-25. (PMID: 21150113); N Engl J Med. 1999 Jul 22;341(4):248-57. (PMID: 10413738); Caspian J Intern Med. 2020 Winter;11(1):12-20. (PMID: 32042381); Horm Res. 1998 Sep;50(3):177-82. (PMID: 9762007); JAMA. 2017 Jun 27;317(24):2515-2523. (PMID: 28655017); Diabetes Care. 2007 Sep;30(9):2236-7. (PMID: 17563345); Bioresour Technol. 2010 Jun;101(12):4676-89. (PMID: 20185303); Diabetes Care. 2019 Mar;42(3):416-426. (PMID: 30104301); Plant Foods Hum Nutr. 2011 Jun;66(2):143-8. (PMID: 21538147); Chem Biol Interact. 2010 Jun 7;186(1):72-81. (PMID: 20363216); Diabetes Spectr. 2014 Aug;27(3):180-8. (PMID: 26246777); Crit Rev Food Sci Nutr. 2011 Jul;51(6):547-62. (PMID: 21929331); BMC Complement Altern Med. 2014 Sep 23;14:351. (PMID: 25249234); Horm Metab Res. 2010 Mar;42(3):187-93. (PMID: 19937569); Sci Rep. 2020 Sep 8;10(1):14790. (PMID: 32901098); Food Chem Toxicol. 2013 Jun;56:398-405. (PMID: 23499750); Diabetes Care. 2016 Sep;39(9):1556-62. (PMID: 27555622); Biomed Pharmacother. 2020 Nov;131:110708. (PMID: 32927252); Korean J Intern Med. 2010 Jun;25(2):119-29. (PMID: 20526383); PPAR Res. 2008;2008:581348. (PMID: 19096709); J Nutr Sci Vitaminol (Tokyo). 2007 Jun;53(3):267-76. (PMID: 17874833); J Am Board Fam Med. 2009 Sep-Oct;22(5):507-12. (PMID: 19734396); Medicine (Baltimore). 2020 Jan;99(1):e18553. (PMID: 31895796); Diabetologia. 2019 Mar;62(3):408-417. (PMID: 30483858); Plants (Basel). 2021 Dec 07;10(12):. (PMID: 34961163); Br J Nutr. 2007 Oct;98(4):720-6. (PMID: 17666145); Am J Physiol. 1999 Aug;277(2):H643-9. (PMID: 10444490); J Clin Invest. 2000 Aug;106(4):467-72. (PMID: 10953021); Pak J Med Sci. 2017 Sep-Oct;33(5):1279-1283. (PMID: 29142579); Diabetes Res Clin Pract. 2003 Dec;62(3):139-48. (PMID: 14625128); Diabetes Res Clin Pract. 2022 Jan;183:109119. (PMID: 34879977); J Biol Chem. 1994 Jan 7;269(1):1-4. (PMID: 8276779); N Engl J Med. 2006 Jun 15;354(24):2552-63. (PMID: 16775236); Clin Nutr. 2019 Apr;38(2):549-556. (PMID: 29605574); J Pak Med Assoc. 2016 Dec;66(12):1637-1642. (PMID: 27924966); Circulation. 2006 Sep 12;114(11):1169-76. (PMID: 16952981); Lancet. 2001 Mar 24;357(9260):905-10. (PMID: 11289345); Fertil Steril. 2007 Jul;88(1):240-3. (PMID: 17296187); PeerJ. 2020 Nov 02;8:e10070. (PMID: 33194379); Ann Glob Health. 2020 Jan 31;86(1):7. (PMID: 32025503); N Engl J Med. 2006 Jun 15;354(24):2596-8. (PMID: 16775241); Eur J Pharmacol. 2019 Nov 5;862:172625. (PMID: 31449807); Bioresour Technol. 2008 Jun;99(9):3908-13. (PMID: 17826984); Bioresour Technol. 2008 Dec;99(18):8783-7. (PMID: 18513962); J Agric Food Chem. 2004 Jan 14;52(1):65-70. (PMID: 14709014); J Pharm Pharmacol. 2019 Dec;71(12):1735-1761. (PMID: 31646653); Rev Diabet Stud. 2014 Fall-Winter;11(3-4):258-66. (PMID: 26177486); PLoS One. 2014 Feb 14;9(2):e87894. (PMID: 24551069) |
| Contributed Indexing: | Keywords: cinnamon; diabetes mellitus; fasting blood glucose; hyperglycemia |
| Entry Date(s): | Date Created: 20230913 Latest Revision: 20230915 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC10494518 |
| DOI: | 10.1177/15593258231200527 |
| PMID: | 37701673 |
| Database: | MEDLINE |
Journal Article; Review